These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7845444)

  • 1. Hyperkalemia due to nafamostat mesylate.
    Kitagawa H; Chang H; Fujita T
    N Engl J Med; 1995 Mar; 332(10):687. PubMed ID: 7845444
    [No Abstract]   [Full Text] [Related]  

  • 2. Brugada-like electrocardiographic pattern due to hyperkalemia.
    Kurisu S; Inoue I; Kawagoe T
    Clin Cardiol; 2009 Jul; 32(7):E23. PubMed ID: 19322892
    [No Abstract]   [Full Text] [Related]  

  • 3. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
    Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
    Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketorolac-induced acute renal failure and hyperkalemia.
    Kelley M; Bastani B
    Clin Nephrol; 1995 Oct; 44(4):276-7. PubMed ID: 8575131
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of hyperkalemia caused by nafamostat mesilate.
    Muto S; Imai M; Asano Y
    Gen Pharmacol; 1995 Dec; 26(8):1627-32. PubMed ID: 8745149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover study.
    Schütt B; Kunz M; Blode H
    J Clin Pharmacol; 2007 Jun; 47(6):774-81. PubMed ID: 17463217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional mechanisms of nafamostat mesilate-associated hyperkalaemia.
    Ookawara S; Tabei K; Sakurai T; Sakairi Y; Furuya H; Asano Y
    Eur J Clin Pharmacol; 1996; 51(2):149-51. PubMed ID: 8911880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperkalemia and celecoxib].
    Rego MJ; Fonseré N; Martí S; Rey-Joly C
    Med Clin (Barc); 2002 Jun; 119(1):36-7. PubMed ID: 12062005
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced hyperkalemia.
    Cannon-Babb ML; Schwartz AB
    Hosp Pract (Off Ed); 1986 Sep; 21(9A):99-107, 111, 114-27. PubMed ID: 2876002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of nafamostat mesilate on the renin-aldosterone system].
    Okamoto T; Marukawa S; Hayami H; Ozaki K; Ishida H; Kono K
    Masui; 1992 Mar; 41(3):326-30. PubMed ID: 1560570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis.
    Takeda K; Matsuno S; Sunamura M; Kakugawa Y
    Am J Surg; 1996 Apr; 171(4):394-8. PubMed ID: 8604829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal failure and hyperkalemia associated with ketorolac tromethamine.
    Pearce CJ; Gonzalez FM; Wallin JD
    Arch Intern Med; 1993 Apr; 153(8):1000-2. PubMed ID: 8481061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NSAID induced-nephropathy].
    Arakawa M
    Ryumachi; 1992 Jun; 32(3):266-9. PubMed ID: 1523528
    [No Abstract]   [Full Text] [Related]  

  • 14. Nafamostat Mesylate Monotherapy in Patients with Moderate COVID-19: a Single-Center, Retrospective Study.
    Soma T; Fujii K; Yoshifuji A; Maruki T; Itoh K; Taniyama D; Kikuchi T; Hasegawa N; Nakamura M
    Jpn J Infect Dis; 2022 Sep; 75(5):484-489. PubMed ID: 35491224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic rounds. Nonsteroidal anti-inflammatory drugs.
    Roy LF; Leenen FH
    Clin Ther; 1987; 9(6):577, 690-2. PubMed ID: 3440271
    [No Abstract]   [Full Text] [Related]  

  • 16. High potassium. Too much of a good thing.
    Mayo Clin Health Lett; 2009 Feb; 27(2):6. PubMed ID: 19360981
    [No Abstract]   [Full Text] [Related]  

  • 17. Diclofenac induced renal dysfunction presenting as cardiac arrhythmia.
    Alva JP; Kotian G
    J Assoc Physicians India; 2001 Jul; 49():749-52. PubMed ID: 11573564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effectiveness and Safety of Nafamostat Mesylate in the Treatment of COVID-19: a Meta-Analysis.
    Wei M; Li T; Liu S; Wang Y; Tran C; Ao G
    Jpn J Infect Dis; 2024 May; 77(3):182-186. PubMed ID: 38296543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional side effects of ACE inhibitors.
    Graves JW
    Am Fam Physician; 2002 Dec; 66(11):2048. PubMed ID: 12484685
    [No Abstract]   [Full Text] [Related]  

  • 20. Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis.
    Sørensen HT; Jacobsen J; Nørgaard M; Pedersen L; Johnsen SP; Baron JA
    Aliment Pharmacol Ther; 2006 Jul; 24(1):111-6. PubMed ID: 16803609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.